Potential Implication of Activating Killer Cell Immunoglobulin-Like Receptor and HLA in Onset of Pulmonary Tuberculosis

Scandinavian Journal of Immunology

Volumn 76, Issue 5, 2012, Pages 491-496

  Lu, C ^a   Bai, X L ^a   Shen, Y J ^a   Deng, Y F ^b   Wang, C Y ^a   Fan, G ^a   Chu, J X ^c   Zhao, S M ^a   Zhang, B C ^a   Zhao, Y R ^a   Zhang, C Z ^a   Ye, H ^a   Lu, Z M ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL CHEST HOSPITAL   (China)

^c JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 1D; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HLA SYSTEM; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-C ANTIGENS; HUMANS; MALE; MIDDLE AGED; RECEPTORS, KIR; TUBERCULOSIS, PULMONARY;

EID: 84867430488     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02762.x     Document Type: Article

References (28)

1. World Health Organization. Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. Geneva, Switzerland: World Health Organization, 2010. ISBN of the reference is 978 92 4 159919 1.
2. Van Crevel R, Ottenhoff THM, van der Meer JWM. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002;15:294-309.
3. Selvaraj P, Alagarasu K, Harishankar M, Vidyarani M, Narayanan PR. Regulatory region polymorphisms of vitamin D receptor gene in pulmonary tuberculosis patients and normal healthy subjects of south India. Int J Immunogenet 2008;35:251-4.
4. Tosh K, Campbell SJ, Fielding K et al. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc Natl Acad Sci USA 2006;103:10364-8.
5. Cooley S, Weisdorf DJ, Guethlein LA et al. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 2010;116:2411-9.
6. Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. Clin Microbiol Rev 2009;22:370-85.
7. Vivian JP, Duncan RC, Berry R et al. Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 2011;479:401-5.
8. Long EO, Rajagopalan S. HLA class I recognition by killer cell Ig-like receptors. Semin Immunol 2000;12:101-8.
9. Falk K, Rotzschke O, Grahovac B et al. Allele-specific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci USA. 1993;90:12005-9.
10. Bergamaschi L, Leone MA, Fasano ME et al. HLA-class I markers and multiple sclerosis susceptibility in the Italian population. Genes Immun 2010;11:173-80.
11. Brusasca PN, Colangeli R, Lyashchenko KP et al. Immunological characterization of antigens encoded by the RD1 region of the Mycobacterium tuberculosis genome. Scand J Immunol 2001;54:448-52.
12. Martin MP, Nelson G, Lee JH et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002;169:2818-22.
13. Hsu KC, Liu XR, Selvakumar A et al. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002;169:5118-29.
14. Bunce M, O'Neill CM, Barnardo MC et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46:355-67.
15. Rodrigues DSS, Medeiros EAS, Weckx LY et al. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease. Clin Exp Immunol 2002;128:149-54.
16. López-Vázquez A, Rodrigo L, Martínez-Borra J et al. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis 2005;192:162-5.
17. Lu ZM, Zhang BC, Chen S et al. Association of KIR genotypes and haplotypes with susceptibility to chronic hepatitis B virus infection in Chinese Han population. Cell Mol Immunol 2008;5:457-63.
18. Malik S, Schurr E. Genetic susceptibility to tuberculosis. Clin Chem Lab Med 2002;40:863-8.
19. Scriba TJ, Kalsdorf B, Abrahams DA et al. Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J Immunol 2008;180:1962-70.
20. Bruns H, Meinken C, Schauenberg P et al. Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest 2009;119:1167-77.
21. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998;391:703-7.
22. Cox RA, Arnold DR, Cook D et al. HLA phenotypes in Mexican Americans with tuberculosis. Am Rev Respir Dis 1982;126:653-5.
23. Jiao YL, Zhang BC, You L et al. Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis. J Clin Immunol 2010;30:840-4.
24. Shi FD, Ljunggren HG, Sarvetnick N. Innate immunity and autoimmunity:From self-protection to self-destruction. Trends Immunol 2001;22:97-101.
25. VandenBussche CJ, Dakshanamurthy S, Posch PE, Hurley CK. A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain. J Immunol 2006;177:5347-57.
26. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 1998;161:571-7.
27. Parham P. MHC class molecules and KIRs in human history health and survival. Natl Rev Immunol 2005;5:201-14.
28. Tajik N, Shah-hosseini A, Mohammadi A et al. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype. Tissue Antigens 2012;79:90-6.